ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Addiction

Addiction

Volume 89 Issue 7, Pages 821 - 830

Published Online: 24 Jan 2006

Journal compilation © 2010 Society for the Study of Addiction



< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: PDF (Size: 2325K)  | Related Articles | Citation Tracking

Systemic absorption and abuse liability of snorted flunitrazepam
ALYSON BOND 1 , DANIEL SEIJAS 1 , SHEILA DAWLING* MALCOLM LADER 1
  1 Department of Psychiatry, Institute of Psychiatry y University of London   *Poisons Unit, Guy's and St Thomas' Hospitals Trust, London, UK
 Correspondence to: Alyson Bond, Department of Psychiatry, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK.
Copyright 1994 Society for the Study of Addiction to Alcohol and Other Drugs

ABSTRACT

AbstractReferences

Benzodiazepine hypnotics are widely abused as pan of a polydrug misuse culture. This study set out to investigate some pharmacokinetic and pharmacodynamic characteristics of a novel method of abuse, snorting, of flunitrazepam. Twenty healthy volunteers took pan: three took 0.5 mg, three took I mg, three took l.5 mg, six took 2 mg and five took placebo. Blood was sampled and ratings of mood, bodily symptoms, strength and liking of drug effect were completed pre- and at 5, 15, 30, 60, 90, 120 and 240 minutes and at 24 hours post-drug. It was found that flunitrasepam could be detected in venous blood 5 minutes after intake. As the dose increased, the peak plasma concentration was higher but also occurred progressively later, the levels reached being comparable to oral or intramuscular administration at 110 minutes. Subjects reported sedation but complained of few side-effects. They liked the drug effects and subjective ratings of strength were correlated with liking and with plasma drug levels.


DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1360-0443.1994.tb00985.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member